What is the Seoulin Bioscience Co., Ltd. stock price forecast?

Seoulin Bioscience Co., Ltd. is currently trading at ₩5,060. View real-time AI analysis on Alpha Lenz.

What is Seoulin Bioscience Co., Ltd. insider trading activity?

View the latest insider trading data for Seoulin Bioscience Co., Ltd. on Alpha Lenz.

What is Seoulin Bioscience Co., Ltd.'s P/E ratio?

Seoulin Bioscience Co., Ltd.'s P/E ratio is 64.3.

Seoulin Bioscience Co., Ltd.

KRX · 038070

₩5,060-60(-1.17%)Market closed

Ask about Seoulin Bioscience Co., Ltd.'s future dividend policy...

Alpha Chat Insight

“Seoulin Bioscience Co., Ltd. trades at a P/E of 64.3 (premium valuation) with modest ROE of 0.9%.”

Ask for details →

Company Overview

Seoulin Bioscience Co., Ltd. is a prominent player within the biopharmaceutical industry, primarily focused on the research, development, and commercialization of innovative biotechnology solutions. With its headquarters in Korea, the company has established a significant presence in the healthcare sector by providing advanced biological research tools and diagnostic products. Seoulin Bioscience caters to a broad spectrum of clientele, including academic institutions, medical research centers, and pharmaceutical companies, by offering high-quality reagents, cell analysis products, and molecular biology kits. Its commitment to driving scientific advancement and improving health outcomes underscores its critical role within the market. By fostering collaborations with research institutions and expanding its product portfolio, Seoulin Bioscience supports the advancement of medical and biotechnological research globally.

CEO황을문, 강미옥 (각자 대표이사)

Websitehttps://www.seoulin.co.kr

SectorHealthcare

IndustryBiotechnology

Employees104

Company Statistics

FY 2025

Profile

₩47,061,420,560Market Cap

₩77,091,299,570Revenue

9.30MShares Out

104Employees

Margins

22.47%Gross

3.45%EBITDA

0.90%Operating

1.15%Pre-Tax

0.74%Net

Valuation

64.29P/E

0.56P/B

0.61EV/Sales

18.80EV/EBITDA

11.07P/FCF

Growth (CAGR)

-9.70%Rev 3Yr

3.44%Rev 5Yr

-57.79%Op Inc 3Yr

-31.15%Op Inc 5Yr

-62.17%Net Inc 3Yr

-34.61%Net Inc 5Yr

Returns

0.52%ROA

0.87%ROE

1.39%ROIC

Financial Health

₩10,452,297,320Cash & Cash Equivalents

₩22,293,963,830Net Debt

38.05%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Seoulin Bioscience Co., Ltd. trades at a P/E of 64.3 (premium valuation) with modest ROE of 0.9%.”

Ask for details →

Frequently Asked Questions

Seoulin Bioscience Co., Ltd. (ticker: 038070) is a company listed on KRX in the Healthcare sector (Biotechnology). It has approximately 104 employees. Market cap is $47.1B.

The current price is ₩5,060 with a P/E ratio of 64.29x and P/B of 0.56x.

ROE is 0.87% and operating margin is 0.90%. Annual revenue is $77.1B.